Back to AMLX
Aldebaran Capital, LLC AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$5.7M
Q3 2026
Peak value
$5.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.4M |
| Q1 2026 | $2.8M |
| Q2 2026 | $3.5M |
| Q3 2026 | $5.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.7M | 196.0K | — | — |
| Q2 2026 | $3.5M | 195.9K | — | — |
| Q1 2026 | $2.8M | 197.9K | — | — |
| Q4 2025 | $2.4M | 198.5K | — | — |
Other funds holding AMLX
$460.9M
$307.7M
$261.7M
$201.3M
$174.7M
$153.5M